A novel clinical signature predicts the survival of elderly patients with oral squamous cell carcinoma

Eur Arch Otorhinolaryngol. 2022 Jan;279(1):391-398. doi: 10.1007/s00405-021-06786-6. Epub 2021 Mar 30.

Abstract

Background: The risk factors for the survival of elderly patients with oral squamous cell carcinoma (OSCC) are multifarious. Here, we developed a novel clinical signature to serve as an indicator of prognosis in these patients.

Materials and methods: Clinicopathological data were collected for 554 patients aged ≥ 60 years who were treated for primary OSCC. Overall survival (OS), disease-specific survival, and disease-free survival were the primary outcomes.

Results: Multivariate cox regression analysis showed that high N stage, low hemoglobin level, low body mass index (BMI), and high neutrophil-to-lymphocyte ratio (NLR) showed a poor survival (P < 0.05). A nomogram was constructed with a c-index of 0.702.

Conclusion: A novel clinical signature including hemoglobin level, BMI, and NLR, which are obtained through noninvasive examinations can be used as prognostic indicators in clinical practice for elderly patients with OSCC.

Keywords: Clinical signature; Elderly patients; Oral squamous cell carcinoma; Prediction model; Prognosis.

MeSH terms

  • Aged
  • Carcinoma, Squamous Cell* / therapy
  • Head and Neck Neoplasms*
  • Humans
  • Lymphocytes
  • Mouth Neoplasms* / therapy
  • Prognosis
  • Squamous Cell Carcinoma of Head and Neck